Home › Autism Spectrum Disorder › NCT03827941

Auricular Transcutaneous Electrical Nerve Stimulation Treatment of Autism

Who can join

Ages 18 to 60 · All sexes

Inclusion Criteria:

1. Autism diagnosed based on DSM-V classification criteria
2. 18-60 year old high functioning adult autism patients (e.g. Asperger's, IQ equal or greater than 80)
3. Subjects who do not show aggressive behaviors based on neuro/psychiatric evaluations as determined by a licensed study physician.

Exclusion Criteria:

1. A history of chronic serious infection, any current infection, any type of cancer or autoimmune disease or other severe diseases;
2. Subjects taking any medications that confound the study results

About the study

In this study, investigators will examine the treatment effects of transcutaneous electrical nerve stimulation with different stimulation frequencies on individuals with autism.

What is being tested

• 1 Hz Auricular transcutaneous electrical nerve stimulation (other)
• 20 Hz Auricular transcutaneous electrical nerve stimulation (other)

Sponsor: Massachusetts General Hospital · Participants: 40 · Started: Nov 1, 2022

Contact the study team

• Sierra Hodges · Phone: 6177267893

Official record on ClinicalTrials.gov — NCT03827941

Locations in the U.S.

Conditions

• Autism Spectrum Disorder

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.